Clinical trial

Skeletal Maturation and Endocrine Health in Young Adults

Invitation only · Not applicable · 1 countries · Registry ID NCT06509776

Invitation onlyNot applicableObservational

What this study is about

Diseases which can be the result of poor lifestyle choices in adult life, such as osteoporosis, obesity or poor muscle mass (sarcopenia) can also be driven by heritable genetic factors. More surprisingly, perhaps, the genes we inherit from our parents can be modified as a result of influences that affected the health and pregnancy of our mothers and hence the environment experienced in the womb and at birth. The purpose of this study is to investigate which factors are needed for good bone health and hormonal health in young adulthood as well as good muscle mass and normal fat mass, and how this is influenced by factors before birth and by childhood health. Specifically, we will measure bone mass and body composition in young adults (18 years of age) and measure hormones in blood and in hair samples. The clinical visits will be available nationwide at several centers to make participation swift and easy for participants. The changes (known as epigenetic modification) to genes at birth will be studied in dried blood spot samples stored from birth 18 years ago in the Danish Serum Institute and we will use national health registers to identify factors during pregnancy and in childhood that contribute to health effects at age 18.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to 19 Years
SexAll
Healthy volunteersNot listed
ConditionOsteoporosis, Sarcopenia, Obesity, Cardiovascular Diseases

Full registry criteria

Inclusion Criteria: * Individuals (n = 2000) born in Denmark in 2006 or 2007 * Are 18 years old and alive at the time of the clinical examination Exclusion Criteria: * Pregnancy or lactation * No DBS samples available * Lack of consent to use DBS samples or national health registries * Emigration or disappearance

Treatments and study arms

The registry does not list a named intervention.

Primary outcomes

Bone Mineral Density of Spine, Hip and Whole-bodyBaseline

The Dual-energy X-ray Absorptiometry (DXA) measures the bone mineral density (BMD) of the spine, hip and whole-body.

Bone Mineral Density of Spine, Hip and Whole-body2 years

The Dual-energy X-ray Absorptiometry (DXA) measures the bone mineral density (BMD) of the spine, hip and whole-body.

Bone Area of Spine, Hip and Whole-bodyBaseline

The Dual-energy X-ray Absorptiometry (DXA) measures the bone area (BA) of the spine, hip and whole-body.

Bone Area of Spine, Hip and Whole-body2 years

The Dual-energy X-ray Absorptiometry (DXA) measures the bone area (BA) of the spine, hip and whole-body.

Bone Mineral Content of Spine, Hip and Whole-bodyBaseline

The Dual-energy X-ray Absorptiometry (DXA) measures the bone mineral content (BMC) in the spine, hip and whole-body.

Bone Mineral Content of Spine, Hip and Whole-body2 years

The Dual-energy X-ray Absorptiometry (DXA) measures the bone mineral content (BMC) in the spine, hip and whole-body.

Study locations

9 locations were listed when this page was built. The first 40 are shown.

Aalborg University Hospital, Department of Endocrinology🇩🇰 Aalborg, Denmark
Aarhus University Hospital, Department of Endocrinology🇩🇰 Aarhus, Denmark
Rigshospitalet, Department of Clinical Biochemistry and Endocrinology🇩🇰 Copenhagen, Denmark
Bispebjerg and Frederiksberg Hospital, EEK, Parker Institute🇩🇰 Frederiksberg, Denmark
Holbæk Hospital, Department of Medicine🇩🇰 Holbæk, Denmark
Hvidovre Hospital, Department of Endocrinology🇩🇰 Hvidovre, Denmark
Zealand University Hospital, Department of Medicine🇩🇰 Køge, Denmark
Odense University Hospital, Department of Endocrinology🇩🇰 Odense, Denmark
University of Southern Denmark, Department of Clinical Research🇩🇰 Odense, Denmark